Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
Anukriti Sharma, Mary M. Buschmann, Jack A. Gilbert
Clinical Pharmacology & Therapeutics (2019) Vol. 106, Iss. 2, pp. 317-328
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review
Zahari Vinarov, Mohammad Abdallah, José A. G. Agúndez, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 162, pp. 105812-105812
Open Access | Times Cited: 226
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Md. Mominur Rahman, Fahadul Islam, Md. Harun- Or-Rashid, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 158
Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 83
Gut Microbiome and Response to Cardiovascular Drugs
Sony Tuteja, Jane F. Ferguson
Circulation Genomic and Precision Medicine (2019) Vol. 12, Iss. 9
Open Access | Times Cited: 99
Microbiome therapeutics: exploring the present scenario and challenges
Monika Yadav, Nar Singh Chauhan
Gastroenterology report (2021) Vol. 10
Open Access | Times Cited: 85
A cross-talk between gut microbiome, salt and hypertension
Salma Naqvi, Turky Omar Asar, Vikas Kumar, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 134, pp. 111156-111156
Open Access | Times Cited: 76
Probiotic Strains and Intervention Total Doses for Modulating Obesity-Related Microbiota Dysbiosis: A Systematic Review and Meta-analysis
Ana López‐Moreno, Antonio Suárez, Camila Avanzi, et al.
Nutrients (2020) Vol. 12, Iss. 7, pp. 1921-1921
Open Access | Times Cited: 72
Effect of Gut Microbiota Biotransformation on Dietary Tannins and Human Health Implications
Ibrahim E. Sallam, Amr Abdelwareth, Heba Attia, et al.
Microorganisms (2021) Vol. 9, Iss. 5, pp. 965-965
Open Access | Times Cited: 65
The Role of Gut Microbiota in the Etiopathogenesis of Multiple Chronic Diseases
Lara Pires, Ana M. Gonzaléz‐Paramás, Sandrina A. Heleno, et al.
Antibiotics (2024) Vol. 13, Iss. 5, pp. 392-392
Open Access | Times Cited: 8
The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy
Romy Aarnoutse, Janine Ziemons, John Penders, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4145-4145
Open Access | Times Cited: 65
Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity
Laurence McEvoy, Daniel F. Carr, Munir Pirmohamed
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 55
The Impact of Diet and Exercise on Drug Responses
Ellen Niederberger, Michael J. Parnham
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7692-7692
Open Access | Times Cited: 50
Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer
Xiaoying Hou, Pei Zhang, Hongzhi Du, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 50
Quantitative Investigation of Irinotecan Metabolism, Transport, and Gut Microbiome Activation
Md Masud Parvez, Abdul Basit, Parth B. Jariwala, et al.
Drug Metabolism and Disposition (2021) Vol. 49, Iss. 8, pp. 683-693
Open Access | Times Cited: 49
Oral Cardiac Drug–Gut Microbiota Interaction in Chronic Heart Failure Patients: An Emerging Association
Ioannis Paraskevaidis, Αlexandros Briasoulis, Elias Tsougos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 6
Gut bacterial microbiome composition and statin intake—A systematic review
Andréia Dias, Gonçalo Cordeiro, María Manuela Estevinho, et al.
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 3
Open Access | Times Cited: 49
Exploring Drug Metabolism by the Gut Microbiota: Modes of Metabolism and Experimental Approaches
Pooja Dhurjad, Chinmayi Dhavaliker, Kajal Gupta, et al.
Drug Metabolism and Disposition (2021) Vol. 50, Iss. 3, pp. 224-234
Open Access | Times Cited: 37
The potential impact of a probiotic: Akkermansia muciniphila in the regulation of blood pressure—the current facts and evidence
Arun Prasath Lakshmanan, Selvasankar Murugesan, Souhaila Al Khodor, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 28
Emerging epigenetic dynamics in gut-microglia brain axis: experimental and clinical implications for accelerated brain aging in schizophrenia
Benneth Ben‐Azu, Elisabetta C. del Re, Jared VanderZwaag, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 15
The Future of Microbiome‐Based Therapeutics in Clinical Applications
Anukriti Sharma, Promi Das, Mary M. Buschmann, et al.
Clinical Pharmacology & Therapeutics (2019) Vol. 107, Iss. 1, pp. 123-128
Closed Access | Times Cited: 42
The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
Yalda Hekmatshoar, Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, et al.
Life Sciences (2019) Vol. 233, pp. 116680-116680
Closed Access | Times Cited: 41
Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury
Merrie Mosedale, Paul B. Watkins
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 12, pp. 6436-6461
Closed Access | Times Cited: 39
Physiologically based pharmacokinetic (PBPK) modelling of oral drug absorption in older adults – an AGePOP review
Cleo Demeester, Donnia Robins, Angela Elma Edwina, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 188, pp. 106496-106496
Open Access | Times Cited: 12
Pharmacometabolomics in Drug Disposition, Toxicity and Precision Medicine
George R Trevor, Yong Jin Lim, Bradley L. Urquhart
Drug Metabolism and Disposition (2024), pp. DMD-001074
Open Access | Times Cited: 4
MDIPID: Microbiota‐drug interaction and disease phenotype interrelation database
Jiayi Yin, Hui Ma, Yuting Qi, et al.
iMeta (2025)
Open Access
Page 1 - Next Page

Scroll to top